[HTML][HTML] Serum interleukin (IL)-23 and IL-17 profile in inflammatory bowel disease (IBD) patients could differentiate between severe and non-severe disease
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[PDF][PDF] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
A Seicean - 2021 - pure.ed.ac.uk
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[PDF][PDF] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
S Din, CA Iuga, A Seicean - J. Pers. Med, 2021 - academia.edu
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[PDF][PDF] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
S Din, CA Iuga, A Seicean - J. Pers. Med, 2021 - researchgate.net
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[PDF][PDF] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
LA Lucaciu, M Ilieș, ȘC Vesa, R Seicean… - Journal of …, 2021 - research.ed.ac.uk
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
LA Lucaciu, M Ilieș, ȘC Vesa… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease.
LA Lucaciu, M Ilieș, ȘC Vesa… - Journal of …, 2021 - search.ebscohost.com
Abstract Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease.
LA Lucaciu, M Ilieș, ȘC Vesa, R Seicean… - Journal of …, 2021 - europepmc.org
Abstract Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[PDF][PDF] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
S Din, CA Iuga, A Seicean - J. Pers. Med, 2021 - pdfs.semanticscholar.org
Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
[HTML][HTML] Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
LA Lucaciu, M Ilieș, ȘC Vesa, R Seicean… - Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …
inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We …